ESHARHIGH SIGNALFINANCIAL10-K

ESHAR experienced a massive balance sheet contraction with total assets declining from $122.3M to $10.0M, indicating potential completion or unwinding of SPAC operations.

The dramatic 92% reduction in total assets alongside the 92% decline in stockholders' equity suggests ESHAR has either completed its business combination or is in the process of liquidating the trust account. The detailed language changes around IPO proceeds, trust account mechanics, and underwriter compensation indicate this is likely a SPAC transitioning from its initial formation phase, which represents a fundamental shift in the company's structure and operations.

Comparing 2025-04-04 vs 2024-04-01View on EDGAR →
FINANCIAL ANALYSIS

ESHAR's financials reflect a complete transformation of its capital structure, with total assets contracting dramatically from $122.3M to $10.0M while liabilities increased modestly to $1.7M. Despite the massive balance sheet contraction, net income roughly doubled year-over-year, though operating losses also expanded meaningfully. The overall picture signals a SPAC that has likely deployed most of its trust account proceeds, fundamentally altering its financial profile and risk characteristics for investors.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+99.2%
$1.9M→$3.9M

Net income grew 99.2% — bottom-line growth signals improving overall business health.

Operating Income
P&L
-95.7%
-$509K→-$996K

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Stockholders Equity
Balance Sheet
-92.1%
$2.2M→$175K

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Total Assets
Balance Sheet
-91.8%
$122.3M→$10.0M

Total assets contracted 91.8% — asset sales, write-downs, or balance sheet optimization underway.

Total Liabilities
Balance Sheet
+59.2%
$1.0M→$1.7M

Liabilities grew 59.2% — significant increase in debt or obligations, assess impact on financial flexibility.

Current Liabilities
Balance Sheet
+59.2%
$1.0M→$1.7M

Current liabilities surged 59.2% — significant near-term obligations; verify ability to meet short-term debt.

Current Assets
Balance Sheet
-32.3%
$2.2M→$1.5M

Current assets declined 32.3% — monitor working capital adequacy and short-term liquidity.

Cash & Equivalents
Balance Sheet
-28.3%
$1.9M→$1.3M

Cash decreased 28.3% — monitor burn rate and upcoming capital needs.

LANGUAGE CHANGES
NEW — 2025-04-04
PRIOR — 2024-04-01
ADDED
$116,725,000 ($10.15 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account pursuant to the Investment Management Trust Agreement, dated June 13, 2023, by and between the Company and Continental Stock Transfer Trust Company, as trustee ( Continental ) (the Trust Agreement and such account the Trust Account ).
On December 17, 2021, the Sponsor subscribed to purchase 8,625,000 shares of the Company s Class B common stock, par value $0.0001 per share (as may be converted to Class A common stock as described below, the Founder Shares ) for a subscription price of $25,000.
A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the IPO held in the Trust Account so that the Trust Account held $10.15 per unit sold directly following the IPO.
On June 16, 2023, the Company issued to I-Bankers 258,750 shares of Class A common stock and to Dawson James 28,750 shares of Class A common stock at the closing of the IPO (collectively, the Representative Shares ).
The Company determined the fair value of the 287,500 Representative Shares to be $2,239,466 (or $7.789 per share) using the Probability-Weighted Expected Return Method Model.
+7 more — sign up free →
REMOVED
$116,725,000 ($10.15 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in the trust account ( Trust Account ) with Continental Stock Transfer Trust Company.
On December 17, 2021, the Sponsor subscribed to purchase 8,625,000 shares of the Company s Class B common stock, par value $0.0001 per share (the Founder Shares ) for a subscription price of $25,000.
A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the IPO held in the Trust Account so that the Trust Account holds $10.15 per unit sold.
The Company incurred offering costs amounting to $5,368,092 as a result of the IPO consisting of a $2,300,000 cash underwriting discount, $2,239,466 fair value of Representative Shares (as defined below), and $828,626 of other offering costs.
Liquidation if No Initial Business Combination Our amended and restated certificate of incorporation provides that we will have only the Combination Period to complete our Initial Business Combination (the Combination Period ).
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →